Leman Biotech的低剂量CAR-T疗法显示100%缓解率

本文如何被排名

Signal score

1 / 100

Composite score across the factors below. Higher = stronger signal that this story matters right now.

Newsworthiness bucket

Significant

文章详细介绍了Leman Biotech（一家由EPFL教授创立的公司）的一种新型CAR-T疗法，该疗法通过独特的代谢增强机制在疗效和成本效益方面取得了显著改善。[lever_c_demoted from frontier_release: ic=1 ai=0.7]

Source corroboration

Single-source cluster

Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.

Topics

model release, product

Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.

AI-industry relevance

High

Clearly on-topic for AI-industry coverage.

Story freshness

1 days old

Coverage has settled into its steady-state source set.

完整方法见我们的编辑标准。